This podcast provides health plan professionals with expert insights on best practices for managing moderate to severe asthma, focusing on type 2 inflammation. Discussion topics include current treatment guidelines, the role of biomarkers in therapy selection, and the impact of biologics on reducing exacerbations and healthcare utilization. Experts also examine challenges in asthma management, such as adherence barriers, care fragmentation, and affordability, while highlighting opportunities for payers to support multidisciplinary care and improve patient outcomes. The conversation underscores the importance of collaboration between payers and providers to ensure appropriate utilization of therapies and enhance access to high-quality asthma care.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-asthma-management-ce/.